Services-Home Health Care Services
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of December 31, 2022, it operated in 252 home health agencies and 105 hospice agencies across 23 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is based in Dallas, Texas.
Discounted Cash Flow Valuation of Enhabit, Inc.
Growth
%
%
Discount
%
%
Multiple
g\r | +10% | +11% | +12% | +13% | +14% |
---|---|---|---|---|---|
0% | 10 | 9 | 8 | 8 | 7 |
+1% | 11 | 10 | 9 | 8 | 8 |
+2% | 13 | 11 | 10 | 9 | 8 |
+3% | 14 | 13 | 11 | 10 | 9 |
+4% | 17 | 14 | 12 | 11 | 10 |
Years | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | TV |
---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF | $44.7M | $20.27M | $9.196M | $4.171M | $1.892M | $858K | $389.2K | $176.5K | $80.06K | $36.31K | $16.47K | $164.7K |
DCF | $17.63M | $6.953M | $2.742M | $1.082M | $426.6K | $168.2K | $66.36K | $26.17K | $10.32K | $4.071K | $40.71K | |
Value | $29.15M |
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 12-2020 | 12-2021 | 12-2022 | TTM |
---|---|---|---|---|
Net Margin | 7% | 10% | -3.8% | -16% |
ROA | - | 8.6% | -0.75% | -10% |
ROE | 5.4% | 7.5% | -5.2% | -24% |
The average Net Margin over the past 5 years is +4.41%.
The trend of Net Margin over the past 5 years is -5.36%.
The average ROA over the past 5 years is +3.93%.
The trend of ROA over the past 5 years is -9.35%.
The average ROE over the past 5 years is +2.56%.
The trend of ROE over the past 5 years is -5.32%.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 12-2020 | 12-2021 | 12-2022 | TTM | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | - | - | 8.30 | 13.00 | ||||||
Debt Equity | - | 0.01 | 0.79 | 0.83 | ||||||
MIN | ||||||||||
Graham Stability | - | - | - | - |
The Debt/FCF trailing twelve month is 13.00.
The trend of Debt/FCF over the past 5 years is -.
Graham’s Stability measure stands at -.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 12-2021 | Trend |
---|---|---|
Revenue | -3.2% | -5.8% |
Net Income | - | - |
Stockholders Equity | -48% | -54% |
FCF | -39% | -490% |
The Revenue CAGR over the past 5 years is -.
The trend of Revenue growth rate over the past 5 years is -5.84%.
The Earnings CAGR over the past 5 years is -.
The trend of Earnings growth rate over the past 5 years is -.
The Equity CAGR over the past 5 years is -.
The trend of Equity growth rate over the past 5 years is -54.27%.
The FCF CAGR over the past 5 years is -.
The trend of FCF growth rate over the past 5 years is -487.04%.